CLINICAL_TRIALS
trial_result
· 2019-09-06
Clinical Trial Update: A Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma [Phase 3]
Summary
Phase 3 trial evaluating safety of tralokinumab in adults and adolescents with uncontrolled asthma was terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Inadequately Controlled Asthma | Phase 3 | Status: TERMINATED | Results posted: 2019-09-06